3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
10
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasm, Residual
1
Neoplasm Metastasis
1
Breast Neoplasms
1
Interventions
Blood Specimen Collection
19
Surveys and Questionnaires
16
Specimen Handling
15
Radiotherapy
6
Magnetic Resonance Spectroscopy
6
trastuzumab deruxtecan
5
Surgical Procedures, Operative
5
Observation
5
darolutamide
4
Patient Reported Outcome Measures
4
Magnetic Resonance Imaging
4
Data Collection
4
Cryosurgery
4
Breath Tests
4
ribociclib
3
atezolizumab
3
Watchful Waiting
3
Ultrasonography
3
Tomography, X-Ray Computed
3
Standard of Care
3
Radiation
3
Letrozole
3
Interviews as Topic
3
Immune Checkpoint Inhibitors
3
Hepatectomy
3
Biopsy
3
Bevacizumab
3
palbociclib
2
lorlatinib
2
cemiplimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Ado-Trastuzumab Emtansine
×
30 days
×
Clear all
NCT06663787
2026-05-13
HER2 CR
Nagoya City University
Active not recruiting
50 enrolled